LIP
TGTX icon

Lighthouse Investment Partners’s TG Therapeutics TGTX Stock Holding History

Lighthouse Investment Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,000
Closed -$936K – 643
2024
Q3 		$936K Sell
40,000
-71,092
-64% -$1.55M 0.04% 334
2024
Q2 		$1.98M Buy
+111,092
New +$1.77M 0.08% 229
2024
Q1 		– Sell
-76,729
Closed -$1.31M – 458
2023
Q4 		$1.31M Buy
+76,729
New +$892K 0.06% 211

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lighthouse Investment Partners's TGTX Position: Q4 2024 in Review

Lighthouse Investment Partners sold out of TG Therapeutics (TGTX) in Q4 2024, closing a stake of 40,000 shares — an estimated $936K sold.

Lighthouse Investment Partners first reported a position in TGTX in Q4 2023 and held it in 3 quarters. The position peaked at $1.98M in Q2 2024. 331 funds tracked by Wall St. Rank hold TGTX as of Q4 2024.

  • Lighthouse Investment Partners reported no remaining TG Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 40,000 TG Therapeutics shares in Q4 2024, an estimated $936K.
  • Lighthouse Investment Partners first reported a position in TG Therapeutics in Q4 2023 and held it in 3 quarters.
  • Lighthouse Investment Partners's TG Therapeutics position peaked at $1.98M in Q2 2024.
  • 331 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2024.

Based on Lighthouse Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.